Prevention and treatment of osteoporosis in inflammatory bowel disease.
Inflamm Bowel Dis. 2006 Aug;12(8):797-813
Authors: Lichtenstein GR, Sands BE, Pazianas M
The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn’s & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.
PMID: 16917235 [PubMed – indexed for MEDLINE]